Z
Zhuhai Beihai Biotechnology
An innovative pharmaceutical research and development enterprise focusing on the research and development of new anti-cancer drugs with patent protection
About Zhuhai Beihai Biotechnology
Beihai Biotech operates in the biotechnology sector, specializing in the development of advanced Peptide Drug Conjugate (PDC) platforms. The company's core technology, known as the Proprietary Precision Delivery Technology Platform, aims to enhance the efficacy and precision of drug delivery systems. Beihai Biotech serves a diverse range of clients, including pharmaceutical companies and research institutions, who are looking to improve their therapeutic outcomes through cutting-edge delivery mechanisms. The company operates on a global scale, leveraging its innovative technology to capture market share in the competitive biotech industry. Beihai Biotech's business model revolves around licensing its proprietary technology to pharmaceutical firms and research organizations, generating revenue through licensing fees and royalties. The company also engages in collaborative research and development projects, further expanding its revenue streams.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Dec 2023 | — | — | Hengguan Investment · GAINS Investment | ↗ |
| SERIES B✓Equity / VC | Oct 2022 | $28M | $110M | Shenzhen Guozhong Venture Capital Management · Yikai Venture Capital · Oriza FOFs · Jinhang | ↗ |
Growth signals
Latest recorded traffic for Zhuhai Beihai Biotechnology is 410 monthly website visits, up 583.3% over the last three months. Zhuhai Beihai Biotechnology's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Zhuhai Beihai Biotechnology in the Zhuhai ecosystem
The Zhuhai Beihai Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Shenzhen Guozhong Venture Capital Management- ZCZhuhai Science & Technology Venture Capital
- CFCEC Capital Future Fund
- YCYikai Venture Capital
Oriza FOFs- JIJinhang
- QIQingdao Hongteng Equity Investment
Series B and later2 investors entered at this stage
- HIHengguan Investment
- GIGAINS Investment
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zhuhai Beihai Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zhuhai Beihai Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








